{"brief_title": "Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia", "brief_summary": "A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia", "condition": "Schizophrenia", "intervention_type": "Drug", "intervention_name": "Placebo", "description": "Tablets, Oral, 0mg, Once daily, 6 weeks.", "arm_group_label": "4", "other_name": "Abilify", "criteria": "Inclusion Criteria: - Men and women, ages 18 and older, with a worsening of schizophrenia symptoms over the past three months", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00080327.xml"}